The health ministry has issued a ban
on the manufacturing and sale of two drugs- Gatifloxacin and Tegaserod.
Gatifloxacin which is an antibiotic and Tegaserod that is used to treat irritable bowel syndrome (IBS) and constipation are likely to cause health risks. Safer alternatives for the same are available in the market.
Gatifloxacin which is an antibiotic and Tegaserod that is used to treat irritable bowel syndrome (IBS) and constipation are likely to cause health risks. Safer alternatives for the same are available in the market.
Several international studies have revealed that when compared to other antibiotics, Gatifloxacin is 17times more likely to cause a surge in the blood sugar level (BSL) among elderly patients. The use of Tegaserod has been associated with an increased risk of heart attack and stroke. Therefore the health ministry decided to ban these drugs under the Drug and Cosmetics Act.
Recommended Reading
Unsafe Drugs- nimesulide, Cisapride, Phenylpropanolamine Banned
After several years of debate regarding the safety of nimesulide, cisapride and phenylpropanolamine (PPA) the DCGI has finally decided to ban these three unsafe drugs.
Sub-committee Formed to Check the Circulation of Banned Drugs in India
The Drug Technical Advisory Board under Drugs & Cosmetics Act has constituted a Sub-committee, to check the circulation of Banned Drugs in India
Indian Government Bans Six Drugs Over Safety Issues
Based on the recommendations of the Expert Committee constituted by DTAB, the Central Government has banned the use of six drugs with immediate effect, over safety issues.
Chinese Herbal Weight Loss Supplement Contains Banned Drugs, FDA Warns
The US drug safety watchdog on Thursday warned that a Chinese herbal slimming supplement sold in shops and online contains active drugs not listed on its label, including a stimulant
